A monthly review of the most important psychedelics research.
October brought us 26 novel publications on psychedelics as medicine. Several studies explored the effects of low doses of LSD, others investigated the positive outcomes
September brought nearly 30 new and exciting papers on psychedelics. Some publications focus on their safety, such as one that looks at LSD in clinical
Psychedelic research continued at pace during the summer of 2021. New research focusing on the risks of psychedelics, the benefits when treating addictions, knowledge of
This month we’ve learned about sleep quality after MDMA, microdosing leaves creativity hanging, and an exciting Phase II study with nitrous oxide was published. The
Psychedelic research in May took another critical step forward. The publication of a large part of the phase III trial data from MAPS showed MDMA-assisted
Psychedelic research in April pitted psychedelics against SSRIs, gave mice a break from tripping, and identified new psychedelics. As we’re awaiting the full results of the MAPS Phase